Research map: When Methods Matter: An Umbrella Review of Lorundrostat and the Impact of Analytical Decisions on Reported Blood Pressure and Safety Outcomes

Back to the article

Papers in this map

  1. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews · Matthew James Page · 2021 · 106363 citations · Cited by this paper
  2. Cardiovascular Pharmacotherapy and Glucose Metabolism: The Good, the Bad and the Unsightly · 2025 · Related
  3. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations · Gordon Henry Guyatt · 2008 · 23433 citations · Cited by this paper
  4. Colchicine for Cardiovascular Prevention: Clarity Amidst the Confusion · 2025 · Related
  5. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both · Beverley Shea · 2017 · 10930 citations · Cited by this paper
  6. Contemporary Oral Medication Use and Frequency in Patients with Transthyretin Amyloid Cardiomyopathy · 2025 · Related
  7. 2018 ESC/ESH Guidelines for the management of arterial hypertension · Bryan Williams · 2018 · 10595 citations · Cited by this paper
  8. Cardiovascular Outcomes Associated with Cholinesterase Inhibitor Use in Individuals at High Cardiovascular Risk · 2025 · Related
  9. A Clinical Trial of the Effects of Dietary Patterns on Blood Pressure · Lawrence J. Appel · 1997 · 6014 citations · Cited by this paper
  10. Redefining Cardiac Sarcoidosis with Advanced Imaging and Therapeutic Strategies · 2025 · Related
  11. Effects on Blood Pressure of Reduced Dietary Sodium and the Dietary Approaches to Stop Hypertension (DASH) Diet · Frank M. Sacks · 2001 · 5665 citations · Cited by this paper
  12. One-Year Prognostic Differences and Management Strategies between ST-Elevation and Non-ST-Elevation Myocardial Infarction: Insights from the PRAISE Registry · 2025 · Related
  13. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 · Mohammad Hossein Forouzanfar · 2015 · 2766 citations · Cited by this paper
  14. De-risking Atrial Fibrillation: Refining Anticoagulation Decision-Making · 2026 · Related
  15. Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015 · Mohammad Hossein Forouzanfar · 2017 · 2464 citations · Cited by this paper
  16. Cost-Effectiveness and Price Threshold Analysis of Tafolecimab in Chinese Patients with Elevated LDL Cholesterol Despite Statin Therapy · 2025 · Related
  17. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension · John William McEvoy · 2024 · 2312 citations · Cited by this paper
  18. Comparative Effectiveness of Sacubitril/Valsartan Versus Sodium-Glucose Cotransporter 2 Inhibitors among Patients with Heart Failure with Reduced Ejection Fraction with or without Diabetes: A Cohort Study · 2026 · Related
  19. Systematic review finds overlapping reviews were not mentioned in every other overview · Dawid Pieper · 2014 · 1341 citations · Cited by this paper
  20. Predictors of New-Onset Kidney Disease in a Community-Based Population · Caroline S. Fox · 2004 · 1260 citations · Cited by this paper
  21. Effects of Protein, Monounsaturated Fat, and Carbohydrate Intake on Blood Pressure and Serum Lipids · Lawrence J. Appel · 2005 · 1173 citations · Cited by this paper
  22. The Impact of Study Size on Meta-analyses: Examination of Underpowered Studies in Cochrane Reviews · Rebecca Turner · 2013 · 678 citations · Cited by this paper
  23. Effects of the DASH Diet Alone and in Combination With Exercise and Weight Loss on Blood Pressure and Cardiovascular Biomarkers in Men and Women With High Blood Pressure · James A. Blumenthal · 2010 · 583 citations · Cited by this paper
  24. RETRACTED: Relationship between Clinic and Ambulatory Blood-Pressure Measurements and Mortality · José R. Banegas · 2018 · 492 citations · Cited by this paper
  25. GPR30 Expression Is Required for the Mineralocorticoid Receptor–Independent Rapid Vascular Effects of Aldosterone · Robert Gros · 2011 · 244 citations · Cited by this paper
  26. Aldosterone Synthase Inhibition With Lorundrostat for Uncontrolled Hypertension · Luke Joseph Laffin · 2023 · 206 citations · Cited by this paper
  27. Twins in Cardiovascular Genetic Research · Friedrich Cameron Luft · 2001 · 125 citations · Cited by this paper
  28. Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension · Luke Joseph Laffin · 2025 · 120 citations · Cited by this paper
  29. Preclinical and Early Clinical Profile of a Highly Selective and Potent Oral Inhibitor of Aldosterone Synthase (CYP11B2) · Katrijn Bogman · 2016 · 112 citations · Cited by this paper
  30. Heritability of Conventional and Ambulatory Blood Pressures · Robert H. Fagard · 1995 · 110 citations · Cited by this paper
  31. Lorundrostat in Participants With Uncontrolled Hypertension and Treatment-Resistant Hypertension · Manish Saxena · 2025 · 94 citations · Cited by this paper
  32. Prevalence, Characteristics, and Association of Obstructive Sleep Apnea with Blood Pressure Control in Patients with Resistant Hypertension · Esther Sapiña-Beltrán · 2019 · 66 citations · Cited by this paper
  33. Efficacy and Safety of Aldosterone Synthase Inhibitors for Hypertension: A Meta-Analysis of Randomized Controlled Trials and Systematic Review · Luigi Antonio Marzano · 2025 · 47 citations · Cited by this paper
  34. Aldosterone Synthase Inhibitors for Resistant Hypertension: Pharmacological Insights – A Systematic Review · Arrigo F.G. Cicero · 2025 · 22 citations · Cited by this paper
  35. Efficacy and safety of aldosterone synthase inhibitors in hypertension: A systematic review and meta- analysis · Rida Siddiqui · 2024 · 20 citations · Cited by this paper
  36. The Emerging Role of Aldosterone Synthase Inhibitors in Overcoming Renin–Angiotensin–Aldosterone System Therapy Limitations: A Narrative Review · Shubh K. Patel · 2025 · 16 citations · Cited by this paper
  37. Efficacy and safety of selective aldosterone synthase inhibitors in uncontrolled hypertension: a systematic review and meta-analysis of randomized controlled trials · Abdelaziz Louat · 2025 · 7 citations · Cited by this paper
  38. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension – How practical is it for clinical practice? · Elisabeta Bădilă · 2024 · 6 citations · Cited by this paper
  39. Efficacy and Safety of Aldosterone Synthase Inhibitors in Hypertension: A Systematic Review and Meta‐Analysis · Jia Shen Goh · 2025 · 6 citations · Cited by this paper

Source: OpenAlex (CC0)